Put Inhaled and Oral COVID-19 Treatments in Perspective
April 2021
You'll be asked whether OUTpatients with COVID-19 should be treated with inhaled corticosteroids, colchicine, or fluvoxamine.
Inhaled steroids and oral colchicine are getting buzz for their anti-inflammatory effects...and fluvoxamine may regulate cytokines.
But emphasize that it's too soon to recommend any of these meds or other oral "cocktails" to treat COVID-19. Overall data are limited...and some studies aren't peer-reviewed or published yet.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote